POST Online Media Lite Edition



 

NEWLY REPORTED COVID-19 CASES (11.19.2021, 4:50pm CEST, WHO):   India 11,106    Brazil 11,977    United Kingdom 46,858    Russia 37,156    Turkey 22,234    France 19,840    Argentina 1,553    Germany 52,970    Spain 3,932    Columbia 2,257    Italy 10,645    Mexico 3,836    Ukraine 20,050    Poland 23,242    Philippines 1,297    Malaysia 6,380    Netherlands 23,680    Peru 1,370    Thailand 6,855    Czechia 13,374    Canada 2,448    Romania 3,076    Chile 2,611    Serbia 3,219    Sweden 1,210    Portugal 2,398    Vietnam 10,223    Kazakhstan 1,272    Austria 14,212    Hungary 11,289    Greece 7,276    Georgia 4,278    Bulgaria 2,785    Belarus 1,844    Slovakia 7,418    Azerbaijan 2,124    Croatia 7,270    Bolivia 1,119    Ireland 4,646    Lithuania 1,847    Denmark 4,013    South Korea 3,034    Slovenia 3,662    Latvia 1,221    Laos 1,401    China 31    New Zealand 200    Australia 1,302   

Thailand plans November human testing for potential coronavirus vaccine

Christian Fernsby |
Thai researchers plan to begin human trials of a potential vaccine for the new coronavirus in November and are preparing 10,000 doses, a senior official said on Sunday, aiming for a vaccine that could be ready for use by late next year.

Article continues below




Following favourable results in trials on primates, the next step is to manufacture doses for human trials, said Kiat Ruxrungtham, director of the Bangkok’s Chulalongkorn University vaccine development program.

“At first we were going to send them in June, but it was not easy to plan everything,” Kiat told a news conference.

There are no approved vaccines for the virus that causes COVID-19, but 19 candidates are being trailed in humans globally. China is leading the race, with an experimental vaccine by Sinovac Biotech Ltd (SVA.O)

Thailand’s first facility should complete production in October and send the products to a second facility, which should finish by November, he said. Originally the earliest target was September, but Kiat said not enough vaccine can be ready by then.

Facilities in San Diego and Vancouver will produce 10,000 doses for the trials for 5,000 people. The first group, aged 18 to 60, will receive different doses of the vaccine, he said.

The trials will not accept volunteers “until we receive approval from the Thai Food and Drug Administration and an ethics committee,” Kiat said.

Thai company BioNet-Asia is preparing its facilities for large-scale manufacturing if the trials prove successful, he said.

“If everything goes according to plan, the vaccine will be ready for Thailand in the third or fourth quarter next year,” Kiat said.


What to read next

Scientists identify new kind of human brain cell
Zika virus infection alters human and viral genes
States are ignoring ACA requirements to cover addiction treatment